StockWatch
·
Pharmaceuticals
Business Update10 Aug 2026, 06:11 pm

Wockhardt Launches Antibiotic Academy to Combat AMR

AI Summary

Wockhardt Ltd has launched the Wockhardt Antibiotic Academy, a patient-centric scientific dialogue initiative aimed at tackling multidrug resistance (AMR). This open scientific learning platform is accessible to registered medical professionals across India, facilitating continuous medical education through knowledge exchange and scientific discussions. The initiative addresses the growing threat of AMR, which causes approximately 10 lakh deaths annually in India due to multi-drug-resistant infections. The Academy seeks to foster a deeper understanding of drug resistance and promote evidence-based solutions to improve patient outcomes. Wockhardt plans to collaborate with clinicians nationwide to strengthen the fight against AMR, emphasizing that saving patient lives through informed clinical decisions is the ultimate measure of success.

Key Highlights

  • Wockhardt launches Antibiotic Academy to address antimicrobial resistance (AMR).
  • Platform aims to foster scientific dialogue and patient-centric solutions for AMR.
  • Initiative targets medical fraternity for knowledge exchange and education.
  • Focuses on improving clinical decisions to save lives from resistant infections.